A Dose-Finding Study of Lenalidomide As Post-Remission Therapy for Older Adults with Acute Myeloid Leukemia (AML)

被引：0
|
作者：
Foster, Matthew C.
Van Deventer, Hendrik W.
Jamieson, Katarzyna
Vincent, Benjamin G.
Matson, Melissa
McKinnon, Karen
Reisdorf, Shannon
Zhang, Jack
Pulley, Will
Muss, Hyman
Ivanova, Anastasia
Zeidner, Joshua F.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2631
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The Value of Post-Remission Therapy in Older Adults with Acute Myeloid Leukemia (AML).
    Sekeres, Mikkael A.
    Fu, Alex Z.
    Earl, Marc
    Kalaycio, Matt
    Advani, Anjali
    Saunthararajah, Yogen
    Sobecks, Ronald
    Copelan, Edward
    [J]. BLOOD, 2009, 114 (22) : 431 - 432
  • [2] Race and Intensity of Post-Remission Therapy in Acute Myeloid Leukemia (AML).
    Brady, Anna K.
    Fu, Alex Z.
    Earl, Marc
    Kalaycio, Matt
    Advani, Anjali
    Saunthararajah, Yogen
    Sobecks, Ronald
    Copelan, Edward
    Sekeres, Mikkael A.
    [J]. BLOOD, 2009, 114 (22) : 419 - 419
  • [3] Post-remission therapy for acute myeloid leukemia
    Schlenk, Richard F.
    [J]. HAEMATOLOGICA, 2014, 99 (11) : 1663 - 1670
  • [4] Post-remission therapy of acute myeloid leukemia in first remission
    Kim, ST
    Kim, K
    Lee, SH
    Kim, WS
    Jung, CW
    Lee, MH
    Park, K
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 59 - 59
  • [5] Should older adults with AML receive post-remission therapy?
    Stone, Richard M.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2015, 28 (2-3) : 106 - 111
  • [6] Phase Ib trial of lenalidomide as post-remission therapy for older adults with acute myeloid leukemia: Safety and longitudinal assessment of geriatric functional domains
    Woods, Justin D.
    Zeidner, Joshua F.
    Van Deventer, Hendrik W.
    Jamieson, Katarzyna
    Matson, Melissa
    Zhang, Jack
    Pulley, William
    Brenizer, Tucker
    Muss, Hyman
    Nyrop, Kirsten A.
    Vohra, Sanah N.
    Deal, Allison M.
    Ivanova, Anastasia
    Foster, Matthew C.
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (04) : 499 - 504
  • [7] Race and intensity of post-remission therapy in acute myeloid leukemia
    Brady, Anna K.
    Fu, Alex Z.
    Earl, Marc
    Kalaycio, Matt
    Advani, Anjali
    Saunthararajah, Yogen
    Sobecks, Ronald
    Copelan, Edward
    Sekeres, Mikkael A.
    [J]. LEUKEMIA RESEARCH, 2011, 35 (03) : 346 - 350
  • [8] Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcome
    B. Bouchacourt
    M. A. Hospital
    C. Zemmour
    J. Rey
    E. d’Incan
    A. Charbonnier
    B. Mohty
    C. Saillard
    S. Bonnet
    A. Collignon
    V. Gelsi-Boyer
    M. J. Mozziconacci
    D. Blaise
    N. Vey
    [J]. Annals of Hematology, 2020, 99 : 773 - 780
  • [9] Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcome
    Bouchacourt, B.
    Hospital, M. A.
    Zemmour, C.
    Rey, J.
    D'Incan, E.
    Charbonnier, A.
    Mohty, B.
    Saillard, C.
    Bonnet, S.
    Collignon, A.
    Gelsi-Boyer, V
    Mozziconacci, M. J.
    Blaise, D.
    Vey, N.
    [J]. ANNALS OF HEMATOLOGY, 2020, 99 (04) : 773 - 780
  • [10] Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia
    El Kinge, Abdul Rahman
    Hatourn, Hassan A.
    Mahfouz, Rami A.
    Otrock, Zaher K.
    Jabbour, Elias
    Kantarjian, Hagop
    Bazarbachi, Ali
    [J]. LEUKEMIA RESEARCH, 2009, 33 (04) : 565 - 566
12345